| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 1 Jul 2025 | 1 Jul 2025 |
| Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on July 01, 2025. | ||
| Board Meeting | 26 May 2025 | 15 May 2025 |
| To consider and approve the financial results for the period ended March 31, 2025 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on May 26, 2025 for Approval of Audited Financial Results for the year ended 31st March, 2025. | ||
| Board Meeting | 19 Apr 2025 | 19 Apr 2025 |
| Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on April 19, 2025 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on April 19, 2025 (As Per NSE Announcement Dated On : 19.04.2025) | ||
| Board Meeting | 13 Feb 2025 | 4 Feb 2025 |
| To consider and approve the financial results for the period ended December 31, 2024 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on February 13, 2025. (As Per NSE Announcement Dated on: 13.02.2025) | ||
| Board Meeting | 3 Jan 2025 | 24 Dec 2024 |
| To consider Fund Raising AJOONI : 03-Jan-2025 : The Company has informed the Exchange that a Board meeting to be held on December 31, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on January 03, 2025, To consider Fund Raising and other business matters (As Per NSE Announcement Dated on: 31/12/2024) Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 03, 2025. (As Per NSE Announcement Dated on: 03.01.2025) | ||
| Board Meeting | 13 Nov 2024 | 4 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024 Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 13, 2024. (As Per NSE Announcement Dated on: 13/11/2024) | ||
| Board Meeting | 13 Nov 2024 | 9 Dec 2024 |
| Ajooni Biotech Limited has informed the Exchange regarding Submission of Outcome of the Board Meeting held on Wednesday, November 13, 2024, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 in Machine Readable Format. | ||
| Board Meeting | 16 Aug 2024 | 9 Aug 2024 |
| To consider other business matters Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on August 16, 2024. (As Per NSE Announcement Dated on:16/08/2024) | ||
| Board Meeting | 9 Aug 2024 | 1 Aug 2024 |
| Financial Results Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended June 30, 2024. Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on August 09, 2024. (As Per NSE Announcement Dated on: 09/08/2024) Ajooni Biotech Limited has informed the Exchange regarding Submission of Un-audited Financial Results for the quarter ended June 30, 2024 in MACHINE READABLE FORMAT. (As Per NSE Announcement Dated on: 21/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.